The TRAIL-sensitivity of Ewing sarcoma (EWS) and osteosarcoma (OS) cell lines have been thoroughly documented [20]; we completed this study with the simultaneous assessment of TRAIL-sensitivity and the sensitivity to DR5-agonist AMG655. This evidence concerns the gene TNFRSF10B and osteosarcoma.